Cutting edge: Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells

Journal of Immunology

Volumn 161, Issue 8, 1998, Pages 3808-3812

  Schoenberger, Stephen P ^a,b   Van Der Voort, Ellen I H ^b   Krietemeijer, G Menno ^b   Offringa, Rienk ^b   Melief, Cornelis J M ^b   Toes, Rene E M ^b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; E1A PROTEIN; E1B PROTEIN; SARCOMA GLYCOPROTEIN GP96 REJECTION ANTIGENS; TUMOR ANTIGEN; VIRUS ANTIGEN;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; ENDOPLASMIC RETICULUM; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; C57BL MOUSE; CYTOTOXICITY; HUMAN; IMMUNOLOGY; ULTRASTRUCTURE;

ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; ENDOPLASMIC RETICULUM; HUMANS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032531539     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283.
2. Bevan, M. J. 1995. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182:639.
3. Heath, W. R., C. Kurts, J. Miller, and F. R. Carbone. 1998. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187: 1549.
4. Huang, A. Y., P. Golumbeck, M. Ahmadzadeh, E. Jaffe, D. M. Pardoll, and H. I. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
5. Srivastava, P. K., A. B. DeLeo, and L. J. Old. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA 83: 3407.
6. Ullrich, S. J., E. A. Robinson, L. W. Law, M. Willingham, and E. Appella. 1986. A mouse tumor-specific transplantation antigen is a heat-shock related protein. Proc. Natl. Acad. Sci. USA 91:3077.
7. Blachere, N. E., Z. Li, R. Y. Chandawarkar, R. Suto, N. S. Jaikaria, S. Basu, H. Udono, and P. K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186:1315.
8. Lindquist, S., and E. A. Craig. 1988. The heat shock proteins. Annu. Rev. Genet. 22:631.
9. Lammert, E., D. Arnold, M. Nijenhuis, F. Momburg, G. J. Hammerling, J. Brunner, S. Stevanovic H. G. Rammensee, and H. Schild. 1997. The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP. Eur. J. Immunol. 27:923.
10. Srivastava, P. K., H. Udono, N. E. Blachere, and Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93.
11. + T cells in vivo. Proc. Natl. Acad. Sci. USA 91:3077.
12. Arnold, D., S. Faath, and H. Rammensee. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with heat shock protein gp96. J. Exp. Med. 182:885.
13. Nieland, T. J., M. C. Tan, M. Monne-van Muijen, F. Koning, A. M. Kruisbeek, and G. M. van Bleek. 1996. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein gp96/GRP94. Proc. Natl. Acad. Sci. USA 93:6135.
14. Suto, R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585.
15. Kast, W. M., R. Offringa, P. J. Peters, A. C. Voordouw, R. H. Meloen, A. J. van der Eb, and C. J. M. Melief. 1989. Eradication of adenovirus E1-induced tumors by E1a-specific cytotoxic T lymphocytes. Cell 59:603.
16. Schoenberger, S. P., L. E. Jonges, R. J. D. Mooijaart, F. Hartgers, R. E. M. Toes, W. M. Kast, C. J. M. Melief, and R. Offringa. 1998. Efficient direct priming of tumor-specific CTL in vivo by an engineered APC. Cancer Res. 58:3094.
17. Harlow, E., B. R. Franza, Jr., and C. Schley. 1985. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogenecity in early region 1A products. J. Virol. 55:533.
18. van den Heuvel, S. J., T. van Laar, W. M. Kast, C. J. Melief, A. Zantema, and A. J. van der Eb. 1990. Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. EMBO J. 19:2621.
19. Toes, R. E. M., R. Offringa, R. J. J. Blom, R. M. P. Brandt, A. J. van der Eb, C. J. M. Melief, and W. M. Kast. 1995. An adenovirus type 5 early region 1B-encoded CTL-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol. 154:3396.
20. Traversari, C., P. van der Bruggen, B. van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytotoxic T lymphocytes. Immunogenetics 35:145.
21. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen-processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489.
22. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. J. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565.
23. Palladino, M. A., Jr., P. K. Srivastava, H. F. Oettgen, and A. B. DeLeo. 1987. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res. 47:5074.
24. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
25. Marusina, K., G. Reid, R. Gabathuler, W. Jeffries, and J. J. Monaco. 1997. Novel peptide binding proteins and peptide transport in normal and TAP-deficient microsomes. Biochemistry 36:856.
26. Spee, P., and J. Neefjes. 1997. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase, and calreticulin. Eur. J. Immunol. 27:2441.
27. Bevan, M. J. 1987. Class discrimination in the world of immunology. Nature 325:192.
28. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Leijendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161.
29. Casciola-Rosen, L., A. Rosen, M. Petri, and M. Schlissel. 1996. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93:1624.
30. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.